The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction
Abstract
Improvements in early detection, supportive care, and treatment have resulted in an increasing number of cancer survivors, with a current 5-year relative survival rate for all cancers combined of approximately 66.1%. For some patients, these survival advances have been offset by the long-term late effects of cancer and its treatment, with second malignant neoplasms (SMNs) comprising one of the most potentially life-threatening sequelae. The number of patients with SMNs is growing, with new SMNs now representing about one in six of all cancers reported to the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. SMNs reflect not only the late effects of therapy but also the influence of shared etiologic factors (in particular, tobacco and excessive alcohol intake), genetic susceptibility, environmental exposures, host effects, and combinations of factors, including gene-environment interactions. For selected SMNs, risk is also modified by age at exposure and attained age. SMNs can be categorized into three major groups according to the predominant etiologic factor(s): (1) treatment-related, (2) syndromic, and (3) those due to shared etiologic exposures, although the nonexclusivity of these groups should be underscored. Here we provide an overview of SMNs in survivors of adult-onset cancer, summarizing the current, albeit limited, clinical evidence with regard to screening and prevention, with a focus on the provision of guidance for health care providers. The growing number of patients with second (and higher-order) cancers mandates that we also further probe etiologic influences and genetic variants that heighten risk, and that we better define high-risk groups for targeted preventive and interventional clinical strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
VASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519
From Cancer Patient to Cancer Survivor: Lost in Transition
(2005) · PsycEXTRA Dataset · doi:10.1037/e720092007-001 · Cited by 2,285
Vogel, V. G. (2006) · JAMA · doi:10.1001/jama.295.23.joc60074 · Cited by 1,652
Self-citationDomchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231205 · Cited by 1,365
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Wolf, A. M. D., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20066 · Cited by 965
Burn, J., Gerdes, A.-M., Macrae, F., Mecklin, J.-P., Moeslein, G., Olschwang, S., Eccles, D., Evans, D. G., Maher, E. R., Bertario, L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61049-0 · Cited by 952
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Engert, A., Plütschow, A., Eich, H. T., Lohri, A., Dörken, B., Borchmann, P., Berger, B., Greil, R., Willborn, K. C., Wilhelm, M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000067 · Cited by 928
Coates, A. S., Keshaviah, A., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R., Castiglione-Gertsch, M., Gelber, R. D., Colleoni, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8617 · Cited by 910
Chlebowski, R. T., Blackburn, G. L., Thomson, C. A., Nixon, D. W., Shapiro, A., Hoy, M. K., Goodman, M. T., Giuliano, A. E., Karanja, N., McAndrew, P., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj494 · Cited by 825
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Travis, L. B., Fosså, S. D., Schonfeld, S. J., McMaster, M. L., Lynch, C. F., Storm, H., Hall, P., Holowaty, E., Andersen, A., Pukkala, E., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji278 · Cited by 823
Self-citationPierce, J. P., Natarajan, L., Caan, B. J., Parker, B. A., Greenberg, E. R., Flatt, S. W., Rock, C. L., Kealey, S., Al-Delaimy, W. K., Bardwell, W. A., et al. (2007) · JAMA · doi:10.1001/jama.298.3.289 · Cited by 734
Hereditary Cancer Predisposition Syndromes
Garber, J. E., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.042 · Cited by 697
Parsons, A., Daley, A., Begh, R., & Aveyard, P. (2010) · BMJ · doi:10.1136/bmj.b5569 · Cited by 696
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
Travis, L. B., Hill, D. A., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Wiklund, T., Lynch, C. F., et al. (2003) · JAMA · doi:10.1001/jama.290.4.465 · Cited by 666
Self-citationSmith, R. A., Cokkinides, V., Brooks, D., Saslow, D., & Brawley, O. W. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20063 · Cited by 660
Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Wade, J. L., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0076 · Cited by 646
Self-citationLindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfeldt, S., Lu, K. H., Lynch, P., Burke, W., & Press, N. (2006) · JAMA · doi:10.1001/jama.296.12.1507 · Cited by 629
Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery
Brenner, D. J., Curtis, R. E., Hall, E. J., & Ron, E. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000115)88:2<398::aid-cncr22>3.0.co;2-v · Cited by 618
Neglia, J. P., Robison, L. L., Stovall, M., Liu, Y., Packer, R. J., Hammond, S., Yasui, Y., Kasper, C. E., Mertens, A. C., Donaldson, S. S., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj411 · Cited by 566
Dores, G. M., Metayer, C., Curtis, R. E., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., van Leeuwen, F. E., Holowaty, E. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.038 · Cited by 565
Self-citationLung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease
Travis, L. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.182 · Cited by 562
Self-citationMultiple Primary Cancers in Families With Li-Fraumeni Syndrome
Hisada, M., Garber, J. E., Li, F. P., Fung, C. Y., & Fraumeni, J. F. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.606 · Cited by 557
State of the epidemiological evidence on physical activity and cancer prevention
Friedenreich, C. M., Neilson, H. K., & Lynch, B. M. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.028 · Cited by 507
Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810818 · Cited by 496
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
Travis, L. B., Curtis, R. E., Fraumeni, J. F., Boice, J. D., Storm, H., Andersson, M., Hall, P., Bergfeldt, K., Holowaty, E., Clarke, E. A., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.19.1429 · Cited by 488
Self-citationKleinerman, R. A., Tucker, M. A., Tarone, R. E., Abramson, D. H., Seddon, J. M., Stovall, M., Li, F. P., & Fraumeni, J. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.054 · Cited by 487
Cancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.1997.03550150066037 · Cited by 486
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Cole, B. F., Logan, R. F., Halabi, S., Benamouzig, R., Sandler, R. S., Grainge, M. J., Chaussade, S., & Baron, J. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn485 · Cited by 476
Hampel, H., Buerger, K., Zinkowski, R., Teipel, S. J., Goernitz, A., Andreasen, N., Sjoegren, M., DeBernardis, J., Kerkman, D., Ishiguro, K., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.95 · Cited by 434
Ng, A. K., Bernardo, M. V. P., Weller, E., Backstrand, K., Silver, B., Marcus, K. C., Tarbell, N. J., Stevenson, M. A., Friedberg, J. W., & Mauch, P. M. (2002) · Blood · doi:10.1182/blood-2002-02-0634 · Cited by 433
Self-citationCancer in the Contralateral Breast after Radiotherapy for Breast Cancer
Boice, J. D., Harvey, E. B., Blettner, M., Stovall, M., & Flannery, J. T. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203193261201 · Cited by 432
Ng, A. K., Bernardo, M. P., Weller, E., Backstrand, K. H., Silver, B., Marcus, K. C., Tarbell, N. J., Friedberg, J., Canellos, G. P., & Mauch, P. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.021 · Cited by 422
Self-citationRobson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0660 · Cited by 421
Cancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
van Leeuwen, F. E., Klokman, W. J., Stovall, M., Dahler, E. C., van't Veer, M. B., Noordijk, E. M., Crommelin, M. A., Aleman, B. M. P., Broeks, A., Gospodarowicz, M., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.971 · Cited by 402
Self-citationRadiation Dose and Second Cancer Risk in Patients Treated for Cancer of the Cervix
Boice, J. D., Engholm, G., Kleinerman, R. A., Blettner, M., Stovall, M., Lisco, H., Moloney, W. C., Austin, D. F., Bosch, A., Cookfair, D. L., et al. (1988) · Radiation Research · doi:10.2307/3577477 · Cited by 394
Sharif, S., Ferner, R., Birch, J. M., Gillespie, J. E., Gattamaneni, H. R., Baser, M. E., & Evans, D. G. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8349 · Cited by 377
Sigurdson, A. J., Ronckers, C. M., Mertens, A. C., Stovall, M., Smith, S. A., Liu, Y., Berkow, R. L., Hammond, S., Neglia, J. P., Meadows, A. T., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66695-0 · Cited by 366
Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer
Travis, L. B., Holowaty, E. J., Bergfeldt, K., Lynch, C. F., Kohler, B. A., Wiklund, T., Curtis, R. E., Hall, P., Andersson, M., Pukkala, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400504 · Cited by 359
Self-citationSecond malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
Kuttesch, J. F., Wexler, L. H., Marcus, R. B., Fairclough, D., Weaver-McClure, L., White, M., Mao, L., Delaney, T. F., Pratt, C. B., Horowitz, M. E., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2818 · Cited by 351
Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma
Hodgson, D. C., Gilbert, E. S., Dores, G. M., Schonfeld, S. J., Lynch, C. F., Storm, H., Hall, P., Langmark, F., Pukkala, E., Andersson, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0936 · Cited by 351
Self-citationTravis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., Chanock, S., DeMichele, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj001 · Cited by 342
Self-citationSecond Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk
Chaturvedi, A. K., Engels, E. A., Gilbert, E. S., Chen, B. E., Storm, H., Lynch, C. F., Hall, P., Langmark, F., Pukkala, E., Kaijser, M., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm201 · Cited by 341
Self-citationStovall, M., Smith, S. A., Langholz, B. M., Boice, J. D., Shore, R. E., Andersson, M., Buchholz, T. A., Capanu, M., Bernstein, L., Lynch, C. F., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.040 · Cited by 329
Lippman, S. M., Lee, J. J., Karp, D. D., Vokes, E. E., Benner, S. E., Goodman, G. E., Khuri, F. R., Marks, R., Winn, R. J., Fry, W., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.605 · Cited by 321
Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies
Azarova, A. M., Lyu, Y. L., Lin, C.-P., Tsai, Y.-C., Lau, J. Y.-N., Wang, J. C., & Liu, L. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704002104 · Cited by 286
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
Chan, A. T., Arber, N., Burn, J., Chia, W. K., Elwood, P., Hull, M. A., Logan, R. F., Rothwell, P. M., Schrör, K., & Baron, J. A. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0391 · Cited by 276
Smith, R. A., Cokkinides, V., Brooks, D., Saslow, D., Shah, M., & Brawley, O. W. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20096 · Cited by 275
Potosky, A. L., Han, P. K. J., Rowland, J., Klabunde, C. N., Smith, T., Aziz, N., Earle, C., Ayanian, J. Z., Ganz, P. A., & Stefanek, M. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1808-4 · Cited by 274
Allan, J. M., Wild, C. P., Rollinson, S., Willett, E. V., Moorman, A. V., Dovey, G. J., Roddam, P. L., Roman, E., Cartwright, R. A., & Morgan, G. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191211198 · Cited by 268
Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application
Freedman, A. N., Seminara, D., Gail, M. H., Hartge, P., Colditz, G. A., Ballard-Barbash, R., & Pfeiffer, R. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji128 · Cited by 267
Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays.
Au, W. W., Salama, S. A., & Sierra-Torres, C. H. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6632 · Cited by 260
Treatment-Associated Leukemia Following Testicular Cancer
Travis, L. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1165 · Cited by 254
Self-citationKirova, Y. M., Vilcoq, J. R., Asselain, B., Sastre‐Garau, X., & Fourquet, A. (2005) · Cancer · doi:10.1002/cncr.21223 · Cited by 251
Bassal, M., Mertens, A. C., Taylor, L., Neglia, J. P., Greffe, B. S., Hammond, S., Ronckers, C. M., Friedman, D. L., Stovall, M., Yasui, Y. Y., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7235 · Cited by 241
Khuri, F. R., Kim, E. S., Lee, J. J., Winn, R. J., Benner, S. E., Lippman, S. M., Fu, K. K., Cooper, J. S., Vokes, E. E., Chamberlain, R. M., et al. (2001) · PubMed · Cited by 241
Therapy-related leukemia and myelodysplasia: susceptibility and incidence
Leone, G., Pagano, L., Ben-Yehuda, D., & Voso, M. T. (2007) · Haematologica · doi:10.3324/haematol.11034 · Cited by 236
Roles of Radiotherapy and Smoking in Lung Cancer Following Hodgkin's Disease
van Leeuwen, F. E., Klokman, W. J., Stovall, M., Hagenbeek, A., van den Belt-Dusebout, A. W., Noyon, R., Boice, J. D., Burgers, J. M. V., & Somers, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.20.1530 · Cited by 234
Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study
Inskip, P. D., Robison, L. L., Stovall, M., Smith, S. A., Hammond, S., Mertens, A. C., Whitton, J. A., Diller, L., Kenney, L., Donaldson, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7738 · Cited by 234
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Metcalfe, K., Gershman, S., Lynch, H. T., Ghadirian, P., Tung, N., Kim-Sing, C., Olopade, O. I., Domchek, S., McLennan, J., Eisen, A., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.120 · Cited by 232 · cited 1×
“Mutations in BRCA1 and BRCA2 are associated with high risks of second primary breast cancer or ovarian cancer.(11,12) Mutations in mismatch repair genes (MLH1, MSH2, PMS1, MSH6) confer an increased risk of a variety of cancers including second primary colon cancers, other gastrointestinal and gynecologic cancers.”
BackgroundSecond Malignant Neoplasms and Cardiovascular Disease Following Radiotherapy
Travis, L. B., Ng, A. K., Allan, J. M., Pui, C.-H., Kennedy, A. R., Xu, X. G., Purdy, J. A., Applegate, K., Yahalom, J., Constine, L. S., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr533 · Cited by 229
Self-citationSecond Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study
Swerdlow, A. J., Higgins, C. D., Smith, P., Cunningham, D., Hancock, B. W., Horwich, A., Hoskin, P. J., Lister, T. A., Radford, J. A., Rohatiner, A. Z. S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8268 · Cited by 222
Prentice, R. L., Thomson, C. A., Caan, B., Hubbell, F. A., Anderson, G. L., Beresford, S. A. A., Pettinger, M., Lane, D. S., Lessin, L., Yasmeen, S., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm159 · Cited by 213
Lung Cancer after Treatment for Hodgkin's Disease: Focus on Radiation Effects
Gilbert, E. S., Stovall, M., Gospodarowicz, M., van Leeuwen, F. E., Andersson, M., Glimelius, B., Joensuu, T., Lynch, C. F., Curtis, R. E., Holowaty, E., et al. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0161:lcatfh]2.0.co;2 · Cited by 206
Self-citationBenner, S. E., Pajak, T. F., Lippman, S. M., Earley, C., & Hong, W. K. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.2.140 · Cited by 201
Secondary Sarcomas in Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study
Henderson, T. O., Whitton, J., Stovall, M., Mertens, A. C., Mitby, P., Friedman, D., Strong, L. C., Hammond, S., Neglia, J. P., Meadows, A. T., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk052 · Cited by 200
Seedhouse, C., Bainton, R., Lewis, M., Harding, A., Russell, N., & Das-Gupta, E. (2002) · Blood · doi:10.1182/blood-2002-04-1152 · Cited by 182
Does intentional weight loss reduce cancer risk?
Byers, T., & Sedjo, R. L. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01464.x · Cited by 177
Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study
Mudie, N. Y., Swerdlow, A. J., Higgins, C. D., Smith, P., Qiao, Z., Hancock, B. W., Hoskin, P. J., & Linch, D. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2200 · Cited by 172
Effect of Breast Cancer Radiotherapy and Cigarette Smoking on Risk of Second Primary Lung Cancer
Kaufman, E. L., Jacobson, J. S., Hershman, D. L., Desai, M., & Neugut, A. I. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3033 · Cited by 169
Best, T., Li, D., Skol, A. D., Kirchhoff, T., Jackson, S. A., Yasui, Y., Bhatia, S., Strong, L. C., Domchek, S. M., Nathanson, K. L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2407 · Cited by 168
Tarella, C., Passera, R., Magni, M., Benedetti, F., Rossi, A., Gueli, A., Patti, C., Parvis, G., Ciceri, F., Gallamini, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9777 · Cited by 168
Goecke, T. O., Schulmann, K., Engel, C., Holinski‐Feder, E., Pagenstecher, C., Schackert, H. K., Kloor, M., Kunstmann, E., Vogelsang, H., Keller, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7333 · Cited by 165
Seedhouse, C., Faulkner, R., Ashraf, N., Das-Gupta, E., & Russell, N. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0372 · Cited by 164
Therapy-associated Solid Tumors
Travis, L. B. (2002) · Acta Oncologica · doi:10.1080/028418602760169361 · Cited by 163
Self-citationRadiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment
Rubino, C., Shamsaldin, A., L�, M. G., Labb�, M., Guinebreti�re, J.-M., Chavaudra, J., & de Vathaire, F. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-2472-8 · Cited by 158
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria
Hampel, H., Sweet, K., Westman, J. A., Offit, K., & Eng, C. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.010918 · Cited by 158
Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome
Limacher, J., Frébourg, T., Natarajan‐Amé, S., & Bergerat, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1021 · Cited by 151
Bernstein, J. L., Haile, R. W., Stovall, M., Boice, J. D., Shore, R. E., Langholz, B. M., Thomas, D. C., Bernstein, L., Lynch, C. F., Olsen, J. H., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq055 · Cited by 151
André, M. P. E. (2003) · Blood · doi:10.1182/blood-2003-04-1124 · Cited by 151
Secondary Malignancies Across the Age Spectrum
Ng, A. K., Kenney, L. B., Gilbert, E. S., & Travis, L. B. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2009.09.002 · Cited by 137
Self-citationDo, K.-A., Johnson, M. M., Lee, J. J., Wu, X. F., Dong, Q., Hong, W. K., Khuri, F. R., & Spitz, M. R. (2004) · Cancer · doi:10.1002/cncr.20714 · Cited by 132
Little, M. P., de Vathaire, F., Shamsaldin, A., Oberlin, O., Campbell, S., Grimaud, E., Chavaudra, J., Haylock, R., & Muirhead, C. R. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981029)78:3<269::aid-ijc1>3.0.co;2-t · Cited by 123
Bolla, M., Lefur, R., Van, J. T., Domenge, C., Badet, J.-M., Koskas, Y., & Laplanche, A. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90290-9 · Cited by 119
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
Hill, D. A. (2005) · Blood · doi:10.1182/blood-2005-04-1535 · Cited by 112
Lung cancer following Hodgkin′s disease: A case‐control study
Kaldor, J. M., Day, N., Bell, J., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520502 · Cited by 107
Richiardi, L., Scélo, G., Boffetta, P., Hemminki, K., Pukkala, ., Olsen, J. H., Weiderpass, E., Tracey, E. A., Brewster, D., McBride, M. L., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22345 · Cited by 102
Roles of Radiation Dose and Chemotherapy in the Etiology of Stomach Cancer as a Second Malignancy
van den Belt‐Dusebout, A. W., Aleman, B. M. P., Besseling, G., Bruin, M. L. D., Hauptmann, M., Veer, M. B. V., de Wit, R., Ribot, J. G., Noordijk, E. M., Kerst, J. M., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.01.073 · Cited by 97
Zablotska, L. B. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi050 · Cited by 94
Secondary malignant neoplasms after Wilms tumor: An international collaborative study
Breslow, N. E., Lange, J. M., Friedman, D. L., Green, D. M., Hawkins, M., Murphy, M. F. G., Neglia, J. P., Olsen, J. H., Peterson, S. M., Stiller, C. A., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.25067 · Cited by 92
Rund, D. G., Krichevsky, S., Cohen, S. B., Goldschmidt, N., Kedmi, M., Malik, E., Gural, A., Shafran‐Tikva, S., Ben‐Neriah, S., & Ben‐Yehuda, D. (2005) · Leukemia · doi:10.1038/sj.leu.2403947 · Cited by 80
Worrillow, L. J., Travis, L. B., Smith, A. G., Rollinson, S. J., Smith, A. J. P., Wild, C. P., Holowaty, E. J., Kohler, B., Wiklund, T. A., Pukkala, ., et al. (2003) · PubMed · doi:10.25405/ncl.34299504 · Cited by 76
Self-citationHoriike, S., Misawa, S., Kaneko, H., Sasai, Y., Kobayashi, M., Fujii, H., Tanaka, S., Yagita, M., Abe, T., Kashima, K., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401466 · Cited by 71
Management of familial melanoma
Newton‐Bishop, J., Harland, M., Randerson‐Moor, J. A., & Bishop, D. T. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)71010-5 · Cited by 69
Seedhouse, C., Das-Gupta, E. P., & Russell, N. H. (2003) · Leukemia · doi:10.1038/sj.leu.2402747 · Cited by 61
Myelodysplastic Syndromes Arising in Patients With Germline TP53 Mutation and Li-Fraumeni Syndrome
Talwalkar, S. S., Yin, C. C., Naeem, R. C., Hicks, J. M., Strong, L. C., & Abruzzo, L. V. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2009-0015-oa.1 · Cited by 60
Mauch, P., Ng, A. K., Aleman, B. M. P., Carde, P. P., Constine, L. S., Diehl, V., Dinshaw, K. A., Gospodarowicz, M. K., Hancock, S., Hodgson, D. C., et al. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00458.x · Cited by 55
Self-citationSecond cancers after testicular cancer diagnosed after 1980 in Sweden
Hemminki, K., Liu, H., & Sundquist, J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp562 · Cited by 55
Casorelli, I. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00020-x · Cited by 52
Bhatia, R. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0659 · Cited by 45
Nutting, C. M., Camplejohn, R., Gilchrist, R., Tait, D., Blake, P., Knee, G., Yao, W. Q., Ross, G., Fisher, C., & Eeles, R. A. (2000) · Clinical Oncology · doi:10.1053/clon.2000.9179 · Cited by 39
Bladder cancer in cancer patients: population-based estimates from a large Swedish study
Bermejo, J. L., Sundquist, J., & Hemminki, K. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605325 · Cited by 38
Gray, J. E., Mao, J. T., Szabo, E. M., Kelley, M. J., Kurie, J. M., & Bepler, G. (2007) · CHEST Journal · doi:10.1378/chest.07-1348 · Cited by 26
Tobacco and the Escalating Global Cancer Burden
Oppeltz, R. F., & Jatoi, I. (2011) · Journal of Oncology · doi:10.1155/2011/408104 · Cited by 24
Genotype Phenotype Correlation in Li-Fraumeni Syndrome Kindreds and its Implications for Management
Moule, R. N., Jhavar, S. G., & Eeles, R. A. (2006) · Familial Cancer · doi:10.1007/s10689-005-4522-8 · Cited by 19
Chemoprevention of Second Cancers
Mayne, S. T., & Cartmel, B. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0415 · Cited by 16
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Abouharb, S., & Litton, J. K. (2012) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2012.03.011 · Cited by 13
Marshall, J. R., & Freudenheim, J. L. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0014 · Cited by 8
Cited by
Andersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., Holland, J. C., Partridge, A. H., Bak, K., Somerfield, M. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4611 · Cited by 735
Multiple primary tumours: challenges and approaches, a review
Vogt, A., Schmid, S., Heinimann, K., Frick, H., Herrmann, C., Cerny, T., & Omlin, A. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000172 · Cited by 628
Nekhlyudov, L., Mollica, M. A., Jacobsen, P. B., Mayer, D. K., Shulman, L. N., & Geiger, A. M. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz089 · Cited by 416
Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
Lustberg, M. B., Kuderer, N. M., Desai, A., Bergerot, C., & Lyman, G. H. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00776-9 · Cited by 306
Metadata
- Authors
- Wood, M. E., Vogel, V., Ng, A., Foxhall, L., Goodwin, P., & Travis, L. B.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-10-20
- Volume
- 30
- Issue
- 30
- Pages
- 3734-3745
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1989412643
- Cited by
- 323
- References
- 118
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.